Verily is an Alphabet precision health company founded in 2015 that builds an AI-native platform to integrate data science, clinical expertise, and advanced technology across the healthcare ecosystem. The company operates Pre, a platform designed to accelerate research, improve patient care, and enable data-driven decision making for health systems, research institutions, and public health organisations.
The company's technical capabilities span artificial intelligence and machine learning, clinical informatics, biomedical device data, public health pathogen surveillance, clinical trials informatics, and virtual care platforms. Verily works with 63 integrated health systems on clinical trials, manages registries with over 750,000 consented participants, provides virtual care services to more than 50,000 patients, and operates public health pathogen tracking across hundreds of US sites.
Verily is headquartered in Dallas with major offices in California, Boston, Raleigh, and Waterloo. The company brings together clinicians, informaticists, engineers, data scientists, and regulatory experts to build healthcare solutions grounded in trustworthy AI principles. Its work spans clinical research, public health surveillance, virtual care delivery, and health data analytics.
